Mild Cognitive Impairment (MCI) Protocol

NeurologicalModerate Evidence

supplements

Primary

Supporting

Grade A

Studies

Primary Stack

Core supplements with strongest evidence

Omega-3 DHAA

1-2g DHA daily

DHA is the primary structural fatty acid in brain cell membranes, supporting neuronal function and reducing neuroinflammation

28 studies4,000 participants

Supporting Studies (2)

PMID: 26890759 - DHA and cognitive function in MCI: meta-analysis (2016)PMID: 29682456 - Omega-3 fatty acids for cognitive decline (2018)

PhosphatidylserineB

100-300mg daily

Essential phospholipid for neuronal membrane integrity and cell signaling, supports memory and cognitive function

↑Forgetting↑Memory

12 studies800 participants

Supporting Studies (1)

PMID: 25168686 - Phosphatidylserine and cognitive function: systematic review (2015)

Supporting Stack

Additional supplements for enhanced results

B Vitamins (B6, B12, Folate)A

B12: 500-1000mcg, B6: 20-50mg, Folate: 800mcg daily

Reduce homocysteine levels, support neurotransmitter synthesis, and slow brain atrophy

↓Cognitive DeclineAlzheimer's Disease Risk↑Cognition

18 studies2,500 participants

Supporting Studies (2)

PMID: 20838622 - B vitamins slow brain atrophy in MCI: VITACOG trial (2010)PMID: 24132566 - Homocysteine-lowering and cognitive outcomes (2013)

Lion's Mane MushroomB

500-3000mg daily

Stimulates nerve growth factor (NGF) production, supporting neurogenesis and myelin formation

↓Cognitive Decline

5 studies200 participants

Supporting Studies (1)

PMID: 18844328 - Lion's mane improves cognitive function in MCI (2009)

How This Protocol Works

Simple Explanation

Mild Cognitive Impairment (MCI) is the stage between normal age-related cognitive changes and dementia. People with MCI have noticeable memory or thinking problems that don't yet interfere with daily life. About 10-15% of people with MCI progress to dementia each year. Supporting brain health during this stage may slow decline.

•Omega-3 DHA makes up about 15% of brain fatty acids and is critical for neuron structure and function. DHA deficiency is associated with cognitive decline, and supplementation may improve memory and processing speed in people with MCI. Higher DHA intake is associated with reduced dementia risk.

•Phosphatidylserine is a phospholipid that makes up 15% of brain phospholipids. It's essential for cell membrane fluidity, neurotransmitter release, and cell signaling. Studies show improvements in memory, learning, and concentration.

•B Vitamins (B6, B12, Folate) are crucial for lowering homocysteine—an amino acid that at high levels damages blood vessels and neurons. The VITACOG trial showed that B vitamins slowed brain shrinkage by 30% in people with MCI who had elevated homocysteine. The effect was strongest in those with adequate omega-3 status.

•Lion's Mane Mushroom is unique in that it stimulates the production of Nerve Growth Factor (NGF), which supports the survival and growth of neurons. Japanese studies show improved cognitive function in older adults with MCI.

Expected timeline: Phosphatidylserine may show benefits within 4-6 weeks. DHA requires 3-6 months for brain incorporation. B vitamin effects on homocysteine occur within weeks; brain atrophy slowing requires longer observation.

Clinical Perspective

MCI involves objective cognitive impairment without significant functional decline. Pathophysiology includes neuroinflammation, oxidative stress, cerebrovascular disease, and early neurodegenerative changes. Annual conversion to dementia is 10-15%. This protocol targets modifiable risk factors.

•Omega-3 DHA (A-grade): Primary omega-3 in neural membranes, comprising 15% of brain fatty acids. Maintains membrane fluidity, supports synaptic plasticity, and resolves neuroinflammation via specialized pro-resolving mediators. Meta-analysis of 28 trials: DHA supplementation improves episodic memory in MCI (PMID: 26890759). Effect more pronounced with early intervention and combined EPA/DHA.

•Phosphatidylserine (B-grade): Anionic phospholipid concentrated in inner neuronal membrane. Essential for PKC activation, calcium signaling, and neurotransmitter release. Systematic review: 100-300mg/day improves memory, learning, and concentration in age-related cognitive decline (PMID: 25168686). Soy-derived PS has replaced bovine cortex-derived.

•B Vitamins (A-grade): Elevated homocysteine is independent risk factor for cognitive decline and brain atrophy. B6 (pyridoxal-5-phosphate), B12 (methylcobalamin), and folate (5-MTHF) required for homocysteine remethylation. VITACOG trial: high-dose B vitamins reduced brain atrophy rate by 30% in MCI with Hcy >11 μmol/L (PMID: 20838622). Effect dependent on adequate omega-3 status—combined supplementation most effective.

•Lion's Mane (B-grade): Hericium erinaceus contains hericenones and erinacines that cross BBB and stimulate NGF synthesis. NGF supports cholinergic neuron survival. Japanese RCT: 3g/day for 16 weeks improved cognitive function scores; benefits reversed after discontinuation (PMID: 18844328).

Biomarker targets: MoCA/MMSE scores, serum homocysteine, B12, folate, RBC DHA (Omega-3 Index), brain MRI volumetrics.

Protocol notes: Check B12 and homocysteine levels before supplementing. MTHFR polymorphisms may require methylfolate. DHA more important than EPA for cognition. Lion's mane: use fruiting body extract, not mycelium. Consider adding citicoline (CDP-choline) or acetyl-L-carnitine. Address vascular risk factors (hypertension, diabetes). Regular exercise has strong evidence for MCI.

View All Protocols